Prothena says Alzheimer’s candidate was safe in early-stage trial (NASDAQ:PRTA)
travellinglight Prothena Corporation (NASDAQ:PRTA) announced Tuesday that PRX005, an Alzheimer's candidate it develops with Bristol Myers ...
Read moretravellinglight Prothena Corporation (NASDAQ:PRTA) announced Tuesday that PRX005, an Alzheimer's candidate it develops with Bristol Myers ...
Read moretravellinglight/iStock through Getty Photos Eisai (OTCPK:ESALF) (OTCPK:ESALY) began submission of knowledge for a biologics license utility ...
Read more Copyright © 2022 Quantann.
Quantann s not responsible for the content of external sites.
Copyright © 2022 Quantann.
Quantann s not responsible for the content of external sites.